Supplemental material
Hematology
Volume 27, 2022 - Issue 1
Research Article
Effectiveness and safety of isavuconazole prophylaxis for invasive fungal infections in the haematologic setting
, , , , 
, , & show all
Tom Macmilland Source Health Economics, London, UKhttps://orcid.org/0000-0001-7274-797XView further author information
https://orcid.org/0000-0001-7274-797XView further author information, , Jalal A. Aramf Pfizer Inc, Groton, CT, USAhttps://orcid.org/0000-0001-5184-1182View further author information
https://orcid.org/0000-0001-5184-1182View further author information & Olaf Penackg Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germanyhttps://orcid.org/0000-0003-4876-802XView further author information
https://orcid.org/0000-0003-4876-802XView further author information show all